These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6713424)

  • 1. Phase II trial of bisantrene in advanced epidermoid carcinoma of the head and neck.
    Forastiere AA; Crain SM; Garbino C; Tipping SJ; Perry DJ; Kasdorf H; Van Echo DA
    Cancer Treat Rep; 1984 Apr; 68(4):687-8. PubMed ID: 6713424
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II trial of amsacrine in metastatic or locally recurrent squamous cell carcinoma from head and neck primaries: a Southwest Oncology Group study.
    Witherspoon RP; Legha SS; Reimer RR; Talley RW; Stuckey WJ; Dixon DO; McCracken JD; Stephens RL; Oishi N
    Cancer Treat Rep; 1984 Feb; 68(2):435-6. PubMed ID: 6546532
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase II trial of vindesine in advanced squamous cell cancer of the head and neck.
    Vogl SE; Camacho FJ; Kaplan BH; O'Donnell MR
    Cancer Treat Rep; 1984 Mar; 68(3):559-60. PubMed ID: 6704987
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase II trial of ICRF-187 in squamous cell carcinoma of the head and neck.
    Wheeler RH; Bricker LJ; Natale RB; Baker SR
    Cancer Treat Rep; 1984 Feb; 68(2):427-8. PubMed ID: 6421483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trial of 4'-epi-doxorubicin in advanced carcinoma of head and neck origin.
    Magee MJ; Howard J; Bosl GJ; Wittes RE
    Cancer Treat Rep; 1985 Jan; 69(1):125-6. PubMed ID: 3855384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II evaluation of diaziquone in recurrent head and neck cancer.
    Kish JA; Ensley J; Al-Sarraf M
    Cancer Treat Rep; 1986 May; 70(5):671-2. PubMed ID: 3708616
    [No Abstract]   [Full Text] [Related]  

  • 7. [Phase II trial of mitoguazone in patients with recurrent extensive cervicofacial tumors].
    Coninx P; Nasca S; Jezekova D; Roelandt H; Morel M; Legros M; Cattan A
    Bull Cancer; 1985; 72(2):153-4. PubMed ID: 4005436
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase II trial of tiazofurin in recurrent squamous cell carcinoma of the head and neck.
    Dimery IW; Neidhart JA; McCarthy K; Krakoff IH; Hong WK
    Cancer Treat Rep; 1987 Apr; 71(4):425-6. PubMed ID: 3548960
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of advanced non-small cell lung cancer with bisantrene.
    Fuks JZ; Van Echo DA; Garbino C; Kasdorf H; Aisner J
    Cancer Treat Rep; 1983 Jun; 67(6):597-8. PubMed ID: 6305499
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase II trial of thioproline in advanced epidermoid head and neck tumors.
    Boccardo F; Barbieri A; Canobbio L; Guarneri D; Merlano M; Rosso R
    Cancer Treat Rep; 1982 Mar; 66(3):585-6. PubMed ID: 7060048
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase II trial of aclarubicin in epidermoid carcinoma of the head and neck.
    Carugati AA; Olivari AJ; Campos DM; Pradier R; Woolley PV
    Cancer Treat Rep; 1986 Jun; 70(6):799-800. PubMed ID: 3524828
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cisplatin and bleomycin in the treatment of advanced or recurrent squamous cell carcinoma of the head and neck. A randomized facultative Phase III controlled study].
    Morton RP; Rugman F; Dorman EB; Stoney PJ; Wilson JA; McCormick M; Veevers A; Stell PM
    Sonderb Strahlenther Onkol; 1987; 81():141-50. PubMed ID: 2435009
    [No Abstract]   [Full Text] [Related]  

  • 13. Phase II clinical trial of L-alanosine in advanced upper aerodigestive cancer.
    Creagan ET; Schutt AJ; Ingle JN; O'Fallon JR
    Cancer Treat Rep; 1983 Nov; 67(11):1047. PubMed ID: 6640554
    [No Abstract]   [Full Text] [Related]  

  • 14. Mitoguazone in advanced squamous cell carcinoma of head and neck origin: a phase II trial of the Southeastern Cancer Study Group.
    Luedke DW; Maddox W; Birch R; Velez-Garcia E; Schleuter J
    Cancer Treat Rep; 1986 Apr; 70(4):529-30. PubMed ID: 3698048
    [No Abstract]   [Full Text] [Related]  

  • 15. Intractable pain in patients with advanced head and neck tumors: a possible role of local infection.
    Bruera E; MacDonald N
    Cancer Treat Rep; 1986 May; 70(5):691-2. PubMed ID: 3708626
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase II trial of bisantrene in hepatocellular carcinoma: a Southwest Oncology Group Study.
    Brown TD; Fleming TR; Shildt RA; Cowan JD
    Cancer Treat Rep; 1987 Nov; 71(11):1101-2. PubMed ID: 2824048
    [No Abstract]   [Full Text] [Related]  

  • 17. Pretreatment probability model for predicting outcome after intraarterial chemoradiation for advanced head and neck carcinoma.
    van den Broek GB; Rasch CR; Pameijer FA; Peter E; van den Brekel MW; Tan IB; Schornagel JH; de Bois JA; Zijp LJ; Balm AJ
    Cancer; 2004 Oct; 101(8):1809-17. PubMed ID: 15386309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II evaluation of mitolactol in squamous cell carcinoma of the head and neck: a Southeastern Cancer Study Group Trial.
    McHale MS; Velez-Garcia E; Nelson O; Williams SD; Maddox W; Birch R
    Cancer Treat Rep; 1986 Jul; 70(7):925-6. PubMed ID: 3521849
    [No Abstract]   [Full Text] [Related]  

  • 19. Phase II trial of pyrazofurin in advanced head and neck cancer.
    Cheng E; Currie V; Wittes RE
    Cancer Treat Rep; 1979; 63(11-12):2047-8. PubMed ID: 526937
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical phase I study of paclitaxel followed by cisplatin in advanced head and neck squamous cell carcinoma.
    Hanauske AR; Schilling T; Heinrich B; Kau R; Herzog M; Quasthoff S; Bochtler H; Diergarten K; Rastetter J
    Semin Oncol; 1995 Dec; 22(6 Suppl 14):35-9. PubMed ID: 8553082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.